These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 33705438)

  • 1. A proteomics approach for the identification of cullin-9 (CUL9) related signaling pathways in induced pluripotent stem cell models.
    Ortolano NA; Romero-Morales AI; Rasmussen ML; Bodnya C; Kline LA; Joshi P; Connelly JP; Rose KL; Pruett-Miller SM; Gama V
    PLoS One; 2021; 16(3):e0248000. PubMed ID: 33705438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytoplasmic E3 ubiquitin ligase CUL9 controls cell proliferation, senescence, apoptosis and genome integrity through p53.
    Li Z; Xiong Y
    Oncogene; 2017 Sep; 36(36):5212-5218. PubMed ID: 28481879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noncanonical assembly, neddylation and chimeric cullin-RING/RBR ubiquitylation by the 1.8 MDa CUL9 E3 ligase complex.
    Horn-Ghetko D; Hopf LVM; Tripathi-Giesgen I; Du J; Kostrhon S; Vu DT; Beier V; Steigenberger B; Prabu JR; Stier L; Bruss EM; Mann M; Xiong Y; Schulman BA
    Nat Struct Mol Biol; 2024 Jul; 31(7):1083-1094. PubMed ID: 38605244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis.
    Pei XH; Bai F; Li Z; Smith MD; Whitewolf G; Jin R; Xiong Y
    Cancer Res; 2011 Apr; 71(8):2969-77. PubMed ID: 21487039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CUL9 mediates the functions of the 3M complex and ubiquitylates survivin to maintain genome integrity.
    Li Z; Pei XH; Yan J; Yan F; Cappell KM; Whitehurst AW; Xiong Y
    Mol Cell; 2014 Jun; 54(5):805-19. PubMed ID: 24793696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish.
    González F
    Dev Dyn; 2016 Jul; 245(7):788-806. PubMed ID: 27145095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a Cul9-Parkin double knockout mouse model for Parkinson's disease.
    Hollville E; Joers V; Nakamura A; Swahari V; Tansey MG; Moy SS; Deshmukh M
    Sci Rep; 2020 Oct; 10(1):16886. PubMed ID: 33037272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly efficient generation of isogenic pluripotent stem cell models using prime editing.
    Li H; Busquets O; Verma Y; Syed KM; Kutnowski N; Pangilinan GR; Gilbert LA; Bateup HS; Rio DC; Hockemeyer D; Soldner F
    Elife; 2022 Sep; 11():. PubMed ID: 36069759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of cell cycle drivers by Cullin-RING ubiquitin ligases.
    Jang SM; Redon CE; Thakur BL; Bahta MK; Aladjem MI
    Exp Mol Med; 2020 Oct; 52(10):1637-1651. PubMed ID: 33005013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells.
    Ihry RJ; Worringer KA; Salick MR; Frias E; Ho D; Theriault K; Kommineni S; Chen J; Sondey M; Ye C; Randhawa R; Kulkarni T; Yang Z; McAllister G; Russ C; Reece-Hoyes J; Forrester W; Hoffman GR; Dolmetsch R; Kaykas A
    Nat Med; 2018 Jul; 24(7):939-946. PubMed ID: 29892062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Scaled Framework for CRISPR Editing of Human Pluripotent Stem Cells to Study Psychiatric Disease.
    Hazelbaker DZ; Beccard A; Bara AM; Dabkowski N; Messana A; Mazzucato P; Lam D; Manning D; Eggan K; Barrett LE
    Stem Cell Reports; 2017 Oct; 9(4):1315-1327. PubMed ID: 29020615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the human GnRH neuron developmental transcriptome using a
    Lund C; Yellapragada V; Vuoristo S; Balboa D; Trova S; Allet C; Eskici N; Pulli K; Giacobini P; Tuuri T; Raivio T
    Dis Model Mech; 2020 Mar; 13(3):. PubMed ID: 31996360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cyclin E1 expression in human pluripotent stem cells and derived neural progeny.
    Rodríguez Varela MS; Mucci S; Videla Richardson GA; Morris Hanon O; Furmento VA; Miriuka SG; Sevlever GE; Scassa ME; Romorini L
    Cell Cycle; 2018; 17(14):1721-1744. PubMed ID: 29995582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semi-automated optimized method to isolate CRISPR/Cas9 edited human pluripotent stem cell clones.
    Frank E; Cailleret M; Nelep C; Fragner P; Polentes J; Herardot E; El Kassar L; Giraud-Triboult K; Monville C; Ben M'Barek K
    Stem Cell Res Ther; 2023 Apr; 14(1):110. PubMed ID: 37106426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent indicators for continuous and lineage-specific reporting of cell-cycle phases in human pluripotent stem cells.
    Chang Y; Hellwarth PB; Randolph LN; Sun Y; Xing Y; Zhu W; Lian XL; Bao X
    Biotechnol Bioeng; 2020 Jul; 117(7):2177-2186. PubMed ID: 32277708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases.
    Zhou W; Wei W; Sun Y
    Cell Res; 2013 May; 23(5):599-619. PubMed ID: 23528706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecules promote CRISPR-Cpf1-mediated genome editing in human pluripotent stem cells.
    Ma X; Chen X; Jin Y; Ge W; Wang W; Kong L; Ji J; Guo X; Huang J; Feng XH; Fu J; Zhu S
    Nat Commun; 2018 Apr; 9(1):1303. PubMed ID: 29610531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Neddylation pathways to inactivate cullin-RING ligases for anticancer therapy.
    Zhao Y; Morgan MA; Sun Y
    Antioxid Redox Signal; 2014 Dec; 21(17):2383-400. PubMed ID: 24410571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An episomal vector-based CRISPR/Cas9 system for highly efficient gene knockout in human pluripotent stem cells.
    Xie Y; Wang D; Lan F; Wei G; Ni T; Chai R; Liu D; Hu S; Li M; Li D; Wang H; Wang Y
    Sci Rep; 2017 May; 7(1):2320. PubMed ID: 28539611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphorylation regulates cullin-based ubiquitination in tumorigenesis.
    Chen Y; Shao X; Cao J; Zhu H; Yang B; He Q; Ying M
    Acta Pharm Sin B; 2021 Feb; 11(2):309-321. PubMed ID: 33643814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.